Skin Elements Limited has lodged an application with the Takeovers Panel alleging undisclosed voting power exceeding 20% via a private placement, raising questions about shareholder rights ahead of critical board spill meetings.
- Skin Elements alleges undisclosed association controlling over 20% voting power
- Placement involved 1.25 billion shares and 625 million options via 62 Capital
- Voting and disposal restrictions reportedly limit investor voting rights
- Company seeks interim orders to delay June 2 EGM and force disclosure
- Potential impact on board spill resolutions scheduled for June 2026
Alleged Undisclosed Voting Power Raises Governance Concerns
Skin Elements Limited (ASX:SKN) has escalated a dispute over control ahead of two extraordinary general meetings (EGMs) scheduled for June 2 and June 23, 2026. The company has applied to the Takeovers Panel alleging that an undisclosed association between 62 Capital Pty Ltd and placement investors holds collective voting power exceeding 20%, potentially breaching sections 606 and 671B of the Corporations Act. This association, if confirmed, could influence the composition of the board during imminent spill meetings.
Details of the Placement and Voting Restrictions
In October 2025, Skin Elements appointed 62 Capital as lead manager for a two-tranche private placement that raised $2.5 million before costs. This placement issued 1.25 billion shares and 625 million unlisted options to professional investors, with 62 Capital receiving 75 million shares and 37.5 million options as lead manager fees. Collectively, these shares represent 43.14% of Skin Elements’ issued capital.
Skin Elements claims that 62 Capital entered into Voting & Disposal Restriction Agreements with the placement investors, imposing limits on voting rights and share disposals. The company asserts these agreements effectively create an undisclosed association, which should have been disclosed under market rules, as it impacts shareholder voting power ahead of the EGMs convened to consider director removals.
Implications for Upcoming Board Spill Meetings
Between March 31 and April 23, 2026, Skin Elements received multiple shareholder notices requisitioning meetings to remove directors. The company argues that the alleged undisclosed association and voting restrictions undermine the efficiency and transparency of the upcoming EGMs, potentially depriving shareholders of critical information to assess the resolutions properly.
In response, Skin Elements is seeking interim orders to disclose the Voting & Disposal Restriction Agreements and, if necessary, to adjourn the June 2 EGM to allow the Takeovers Panel time to investigate. Final orders sought include preventing the associates from exercising voting rights above 20%, declaring the agreements unenforceable, and barring them from influencing board appointments or removals.
Background on Skin Elements’ Capital Raises and Market Position
This latest development follows a series of capital raises and strategic moves by Skin Elements to fund its biotechnology operations and product rollouts. The $2.5 million placement managed by 62 Capital in late 2025 was part of a broader effort to commercialise natural antimicrobial products and expand its market footprint, including a recent move into gold mining assets in Western Australia. The company’s financials have shown pressure, with a reported $4 million loss in the half-year ending December 2025, despite securing fresh capital to support growth initiatives.
Given the scale of the placement and the role of 62 Capital, the alleged undisclosed association casts a spotlight on governance and disclosure practices at a critical juncture for Skin Elements. The situation also raises questions about the transparency of voting arrangements in private placements and their potential to affect control dynamics in smaller ASX-listed companies.
Skin Elements’ application to the Takeovers Panel comes as the market awaits clarity on whether the Panel will conduct proceedings and what interim measures might be imposed. The outcome could set important precedents for how voting restrictions and associations are disclosed and managed in future capital raisings.
Bottom Line?
The Takeovers Panel’s response will be pivotal in clarifying voting power disclosures ahead of Skin Elements’ board spill, potentially reshaping control dynamics.
Questions in the middle?
- Will the Takeovers Panel grant interim orders delaying the June 2 EGM?
- How might disclosure of voting restrictions affect shareholder voting behaviour?
- Could this case influence future regulatory scrutiny of private placement voting arrangements?